The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biosimilar Insulin Lispro Market Research Report 2025
Synopsis
Insulin lispro Sanofi is a 'biosimilar medicine'. This means that it is highly similar to a biological medicine (also known as the 'reference medicine') that is already authorised in the European Union (EU). The reference medicine for Insulin lispro Sanofi is Humalog 100 U/ml solution
The global Biosimilar Insulin Lispro market was valued at US$ 511.6 million in 2023 and is anticipated to reach US$ 619 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biosimilar Insulin Lispro, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Insulin Lispro.
Report Scope
The Biosimilar Insulin Lispro market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosimilar Insulin Lispro market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Insulin Lispro manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Gan&Lee
Geropharm
Segment by Type
Pre-filled
Cartridge
Segment by Application
Hospital
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biosimilar Insulin Lispro manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biosimilar Insulin Lispro in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Insulin lispro Sanofi is a 'biosimilar medicine'. This means that it is highly similar to a biological medicine (also known as the 'reference medicine') that is already authorised in the European Union (EU). The reference medicine for Insulin lispro Sanofi is Humalog 100 U/ml solution
The global Biosimilar Insulin Lispro market was valued at US$ 511.6 million in 2023 and is anticipated to reach US$ 619 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biosimilar Insulin Lispro, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Insulin Lispro.
Report Scope
The Biosimilar Insulin Lispro market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosimilar Insulin Lispro market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Insulin Lispro manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Gan&Lee
Geropharm
Segment by Type
Pre-filled
Cartridge
Segment by Application
Hospital
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biosimilar Insulin Lispro manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biosimilar Insulin Lispro in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Biosimilar Insulin Lispro Market Overview
1.1 Product Overview and Scope of Biosimilar Insulin Lispro
1.2 Biosimilar Insulin Lispro Segment by Type
1.2.1 Global Biosimilar Insulin Lispro Market Value Comparison by Type (2024-2030)
1.2.2 Pre-filled
1.2.3 Cartridge
1.3 Biosimilar Insulin Lispro Segment by Application
1.3.1 Global Biosimilar Insulin Lispro Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Biosimilar Insulin Lispro Market Size Estimates and Forecasts
1.4.1 Global Biosimilar Insulin Lispro Revenue 2019-2030
1.4.2 Global Biosimilar Insulin Lispro Sales 2019-2030
1.4.3 Global Biosimilar Insulin Lispro Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biosimilar Insulin Lispro Market Competition by Manufacturers
2.1 Global Biosimilar Insulin Lispro Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biosimilar Insulin Lispro Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biosimilar Insulin Lispro Average Price by Manufacturers (2019-2024)
2.4 Global Biosimilar Insulin Lispro Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biosimilar Insulin Lispro, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biosimilar Insulin Lispro, Product Type & Application
2.7 Biosimilar Insulin Lispro Market Competitive Situation and Trends
2.7.1 Biosimilar Insulin Lispro Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biosimilar Insulin Lispro Players Market Share by Revenue
2.7.3 Global Biosimilar Insulin Lispro Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biosimilar Insulin Lispro Retrospective Market Scenario by Region
3.1 Global Biosimilar Insulin Lispro Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biosimilar Insulin Lispro Global Biosimilar Insulin Lispro Sales by Region: 2019-2030
3.2.1 Global Biosimilar Insulin Lispro Sales by Region: 2019-2024
3.2.2 Global Biosimilar Insulin Lispro Sales by Region: 2025-2030
3.3 Global Biosimilar Insulin Lispro Global Biosimilar Insulin Lispro Revenue by Region: 2019-2030
3.3.1 Global Biosimilar Insulin Lispro Revenue by Region: 2019-2024
3.3.2 Global Biosimilar Insulin Lispro Revenue by Region: 2025-2030
3.4 North America Biosimilar Insulin Lispro Market Facts & Figures by Country
3.4.1 North America Biosimilar Insulin Lispro Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biosimilar Insulin Lispro Sales by Country (2019-2030)
3.4.3 North America Biosimilar Insulin Lispro Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biosimilar Insulin Lispro Market Facts & Figures by Country
3.5.1 Europe Biosimilar Insulin Lispro Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biosimilar Insulin Lispro Sales by Country (2019-2030)
3.5.3 Europe Biosimilar Insulin Lispro Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biosimilar Insulin Lispro Market Facts & Figures by Country
3.6.1 Asia Pacific Biosimilar Insulin Lispro Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biosimilar Insulin Lispro Sales by Country (2019-2030)
3.6.3 Asia Pacific Biosimilar Insulin Lispro Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biosimilar Insulin Lispro Market Facts & Figures by Country
3.7.1 Latin America Biosimilar Insulin Lispro Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biosimilar Insulin Lispro Sales by Country (2019-2030)
3.7.3 Latin America Biosimilar Insulin Lispro Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biosimilar Insulin Lispro Market Facts & Figures by Country
3.8.1 Middle East and Africa Biosimilar Insulin Lispro Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biosimilar Insulin Lispro Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biosimilar Insulin Lispro Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biosimilar Insulin Lispro Sales by Type (2019-2030)
4.1.1 Global Biosimilar Insulin Lispro Sales by Type (2019-2024)
4.1.2 Global Biosimilar Insulin Lispro Sales by Type (2025-2030)
4.1.3 Global Biosimilar Insulin Lispro Sales Market Share by Type (2019-2030)
4.2 Global Biosimilar Insulin Lispro Revenue by Type (2019-2030)
4.2.1 Global Biosimilar Insulin Lispro Revenue by Type (2019-2024)
4.2.2 Global Biosimilar Insulin Lispro Revenue by Type (2025-2030)
4.2.3 Global Biosimilar Insulin Lispro Revenue Market Share by Type (2019-2030)
4.3 Global Biosimilar Insulin Lispro Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biosimilar Insulin Lispro Sales by Application (2019-2030)
5.1.1 Global Biosimilar Insulin Lispro Sales by Application (2019-2024)
5.1.2 Global Biosimilar Insulin Lispro Sales by Application (2025-2030)
5.1.3 Global Biosimilar Insulin Lispro Sales Market Share by Application (2019-2030)
5.2 Global Biosimilar Insulin Lispro Revenue by Application (2019-2030)
5.2.1 Global Biosimilar Insulin Lispro Revenue by Application (2019-2024)
5.2.2 Global Biosimilar Insulin Lispro Revenue by Application (2025-2030)
5.2.3 Global Biosimilar Insulin Lispro Revenue Market Share by Application (2019-2030)
5.3 Global Biosimilar Insulin Lispro Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Biosimilar Insulin Lispro Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Biosimilar Insulin Lispro Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Gan&Lee
6.2.1 Gan&Lee Corporation Information
6.2.2 Gan&Lee Description and Business Overview
6.2.3 Gan&Lee Biosimilar Insulin Lispro Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gan&Lee Biosimilar Insulin Lispro Product Portfolio
6.2.5 Gan&Lee Recent Developments/Updates
6.3 Geropharm
6.3.1 Geropharm Corporation Information
6.3.2 Geropharm Description and Business Overview
6.3.3 Geropharm Biosimilar Insulin Lispro Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Geropharm Biosimilar Insulin Lispro Product Portfolio
6.3.5 Geropharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biosimilar Insulin Lispro Industry Chain Analysis
7.2 Biosimilar Insulin Lispro Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biosimilar Insulin Lispro Production Mode & Process
7.4 Biosimilar Insulin Lispro Sales and Marketing
7.4.1 Biosimilar Insulin Lispro Sales Channels
7.4.2 Biosimilar Insulin Lispro Distributors
7.5 Biosimilar Insulin Lispro Customers
8 Biosimilar Insulin Lispro Market Dynamics
8.1 Biosimilar Insulin Lispro Industry Trends
8.2 Biosimilar Insulin Lispro Market Drivers
8.3 Biosimilar Insulin Lispro Market Challenges
8.4 Biosimilar Insulin Lispro Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Biosimilar Insulin Lispro Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Biosimilar Insulin Lispro Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Biosimilar Insulin Lispro Market Competitive Situation by Manufacturers in 2023
Table 4. Global Biosimilar Insulin Lispro Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Biosimilar Insulin Lispro Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Biosimilar Insulin Lispro Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Biosimilar Insulin Lispro Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Biosimilar Insulin Lispro Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Biosimilar Insulin Lispro, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biosimilar Insulin Lispro, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biosimilar Insulin Lispro, Product Type & Application
Table 12. Global Key Manufacturers of Biosimilar Insulin Lispro, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biosimilar Insulin Lispro by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Insulin Lispro as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biosimilar Insulin Lispro Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Biosimilar Insulin Lispro Sales by Region (2019-2024) & (K Units)
Table 18. Global Biosimilar Insulin Lispro Sales Market Share by Region (2019-2024)
Table 19. Global Biosimilar Insulin Lispro Sales by Region (2025-2030) & (K Units)
Table 20. Global Biosimilar Insulin Lispro Sales Market Share by Region (2025-2030)
Table 21. Global Biosimilar Insulin Lispro Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Biosimilar Insulin Lispro Revenue Market Share by Region (2019-2024)
Table 23. Global Biosimilar Insulin Lispro Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Biosimilar Insulin Lispro Revenue Market Share by Region (2025-2030)
Table 25. North America Biosimilar Insulin Lispro Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Biosimilar Insulin Lispro Sales by Country (2019-2024) & (K Units)
Table 27. North America Biosimilar Insulin Lispro Sales by Country (2025-2030) & (K Units)
Table 28. North America Biosimilar Insulin Lispro Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Biosimilar Insulin Lispro Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Biosimilar Insulin Lispro Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Biosimilar Insulin Lispro Sales by Country (2019-2024) & (K Units)
Table 32. Europe Biosimilar Insulin Lispro Sales by Country (2025-2030) & (K Units)
Table 33. Europe Biosimilar Insulin Lispro Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Biosimilar Insulin Lispro Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Biosimilar Insulin Lispro Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Biosimilar Insulin Lispro Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Biosimilar Insulin Lispro Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Biosimilar Insulin Lispro Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Biosimilar Insulin Lispro Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biosimilar Insulin Lispro Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Biosimilar Insulin Lispro Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Biosimilar Insulin Lispro Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Biosimilar Insulin Lispro Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Biosimilar Insulin Lispro Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Biosimilar Insulin Lispro Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Biosimilar Insulin Lispro Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Biosimilar Insulin Lispro Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Biosimilar Insulin Lispro Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Biosimilar Insulin Lispro Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Biosimilar Insulin Lispro Sales (K Units) by Type (2019-2024)
Table 51. Global Biosimilar Insulin Lispro Sales (K Units) by Type (2025-2030)
Table 52. Global Biosimilar Insulin Lispro Sales Market Share by Type (2019-2024)
Table 53. Global Biosimilar Insulin Lispro Sales Market Share by Type (2025-2030)
Table 54. Global Biosimilar Insulin Lispro Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Biosimilar Insulin Lispro Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Biosimilar Insulin Lispro Revenue Market Share by Type (2019-2024)
Table 57. Global Biosimilar Insulin Lispro Revenue Market Share by Type (2025-2030)
Table 58. Global Biosimilar Insulin Lispro Price (US$/Unit) by Type (2019-2024)
Table 59. Global Biosimilar Insulin Lispro Price (US$/Unit) by Type (2025-2030)
Table 60. Global Biosimilar Insulin Lispro Sales (K Units) by Application (2019-2024)
Table 61. Global Biosimilar Insulin Lispro Sales (K Units) by Application (2025-2030)
Table 62. Global Biosimilar Insulin Lispro Sales Market Share by Application (2019-2024)
Table 63. Global Biosimilar Insulin Lispro Sales Market Share by Application (2025-2030)
Table 64. Global Biosimilar Insulin Lispro Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Biosimilar Insulin Lispro Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Biosimilar Insulin Lispro Revenue Market Share by Application (2019-2024)
Table 67. Global Biosimilar Insulin Lispro Revenue Market Share by Application (2025-2030)
Table 68. Global Biosimilar Insulin Lispro Price (US$/Unit) by Application (2019-2024)
Table 69. Global Biosimilar Insulin Lispro Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Biosimilar Insulin Lispro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Biosimilar Insulin Lispro Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Gan&Lee Corporation Information
Table 76. Gan&Lee Description and Business Overview
Table 77. Gan&Lee Biosimilar Insulin Lispro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Gan&Lee Biosimilar Insulin Lispro Product
Table 79. Gan&Lee Recent Developments/Updates
Table 80. Geropharm Corporation Information
Table 81. Geropharm Description and Business Overview
Table 82. Geropharm Biosimilar Insulin Lispro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Geropharm Biosimilar Insulin Lispro Product
Table 84. Geropharm Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Biosimilar Insulin Lispro Distributors List
Table 88. Biosimilar Insulin Lispro Customers List
Table 89. Biosimilar Insulin Lispro Market Trends
Table 90. Biosimilar Insulin Lispro Market Drivers
Table 91. Biosimilar Insulin Lispro Market Challenges
Table 92. Biosimilar Insulin Lispro Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biosimilar Insulin Lispro
Figure 2. Global Biosimilar Insulin Lispro Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Biosimilar Insulin Lispro Market Share by Type in 2023 & 2030
Figure 4. Pre-filled Product Picture
Figure 5. Cartridge Product Picture
Figure 6. Global Biosimilar Insulin Lispro Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Biosimilar Insulin Lispro Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Others
Figure 11. Global Biosimilar Insulin Lispro Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Biosimilar Insulin Lispro Market Size (2019-2030) & (US$ Million)
Figure 13. Global Biosimilar Insulin Lispro Sales (2019-2030) & (K Units)
Figure 14. Global Biosimilar Insulin Lispro Average Price (US$/Unit) & (2019-2030)
Figure 15. Biosimilar Insulin Lispro Report Years Considered
Figure 16. Biosimilar Insulin Lispro Sales Share by Manufacturers in 2023
Figure 17. Global Biosimilar Insulin Lispro Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Biosimilar Insulin Lispro Players: Market Share by Revenue in 2023
Figure 19. Biosimilar Insulin Lispro Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Biosimilar Insulin Lispro Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Biosimilar Insulin Lispro Sales Market Share by Country (2019-2030)
Figure 22. North America Biosimilar Insulin Lispro Revenue Market Share by Country (2019-2030)
Figure 23. United States Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Biosimilar Insulin Lispro Sales Market Share by Country (2019-2030)
Figure 26. Europe Biosimilar Insulin Lispro Revenue Market Share by Country (2019-2030)
Figure 27. Germany Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Biosimilar Insulin Lispro Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Biosimilar Insulin Lispro Revenue Market Share by Region (2019-2030)
Figure 34. China Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Biosimilar Insulin Lispro Sales Market Share by Country (2019-2030)
Figure 44. Latin America Biosimilar Insulin Lispro Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Biosimilar Insulin Lispro Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Biosimilar Insulin Lispro Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Biosimilar Insulin Lispro Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Biosimilar Insulin Lispro by Type (2019-2030)
Figure 54. Global Revenue Market Share of Biosimilar Insulin Lispro by Type (2019-2030)
Figure 55. Global Biosimilar Insulin Lispro Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Biosimilar Insulin Lispro by Application (2019-2030)
Figure 57. Global Revenue Market Share of Biosimilar Insulin Lispro by Application (2019-2030)
Figure 58. Global Biosimilar Insulin Lispro Price (US$/Unit) by Application (2019-2030)
Figure 59. Biosimilar Insulin Lispro Value Chain
Figure 60. Biosimilar Insulin Lispro Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
